Changchun High and New Technology Industries Group Overview

  • Year Founded
  • 1993

Year Founded

  • Status
  • Public

  • Employees
  • 10,080

Employees

  • Stock Symbol
  • 000661

Stock Symbol

  • Investments
  • 15

  • Share Price
  • $10.56
  • (As of Friday Closing)

Changchun High and New Technology Industries Group General Information

Description

Changchun High-Tech Industry (Group) Co Ltd is engaged in the production and sales of biopharmaceuticals, Chinese patent medicine production, and real estate development. The company operates its business through three segments. The Pharmaceuticals segment focuses on the research and development, manufacturing, and sales of genetically engineered biologics, human vaccines, traditional Chinese medicines, and chemical pharmaceuticals. The Real Estate segment is involved in property development and sales. The Services segment provides scientific research and technical support, along with leasing and various business-related services. It generates the majority of its revenue from the Pharmaceuticals segment.

Contact Information

Website
www.ccht.jl.cn
Formerly Known As
Changchun High & New Technology Industry Development Corporation
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Room 2708, Building B, Hairong Hotel
  • Haiyin Plaza Office Building, High-tech Zone
  • Changchun, Jilin 130021
  • China
+86 0431
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Stock Exchange
SHE
Vertical(s)
Corporate Office
  • Room 2708, Building B, Hairong Hotel
  • Haiyin Plaza Office Building, High-tech Zone
  • Changchun, Jilin 130021
  • China
+86 0431

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Changchun High and New Technology Industries Group Stock Performance

As of 13-Nov-2026, Changchun High and New Technology Industries Group’s stock price is $10.56. Its current market cap is $4.31B with 408M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.56 $10.65 $8.99 - $15.43 $4.31B 408M 5.32M -$0.15

Changchun High and New Technology Industries Group Financials Summary

As of 30-Sep-2026, Changchun High and New Technology Industries Group has a trailing 12-month revenue of $1.53B.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 4,402,818 5,465,224 5,290,886 7,886,712
Revenue 1,527,353 1,680,240 1,876,622 2,058,839
EBITDA (70,811) 105,019 511,070 840,832
Net Income (61,483) 21,550 359,985 640,645
Total Assets 4,662,151 4,299,244 4,253,520 4,337,055
Total Debt 343,461 276,862 213,958 205,370
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Changchun High and New Technology Industries Group Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Changchun High and New Technology Industries Group‘s full profile, request access.

Request a free trial

Changchun High and New Technology Industries Group Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Changchun High and New Technology Industries Group Investments & Acquisitions (15)

Changchun High and New Technology Industries Group’s most recent deal was a Corporate with Reinovax Biologics. The deal was made on 16-May-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Reinovax Biologics 16-May-2025 Corporate Drug Discovery
Matwings Technology 22-Jan-2025 Early Stage VC Discovery Tools (Healthcare)
Coval Biopharma 15-Mar-2022 Merger/Acquisition Drug Discovery
Coval Biopharma 15-Mar-2022 Early Stage VC Drug Discovery
Hangzhou Wowei Medical 10-Feb-2022 Secondary Transaction - Private Monitoring Equipment
You’re viewing 5 of 15 investments and acquisitions. Get the full list »

Changchun High and New Technology Industries Group ESG

Risk Overview

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Pharmaceuticals

Industry

Rank

Percentile

Biotechnology

Subindustry

Rank

Percentile

To view Changchun High and New Technology Industries Group’s complete esg history, request access »

Changchun High and New Technology Industries Group Exits (2)

Changchun High and New Technology Industries Group’s most recent exit was on 28-May-2020 from BCHT. The exit was categorized as with 2 buyers.

Company Name Exit Date Exit Type Exit Size Status Buyers
BCHT 28-May-2020 Completed
  • 2 buyers
Rani Therapeutics 22-Dec-2017 Later Stage VC Completed
  • 15 buyers
To view Changchun High and New Technology Industries Group’s complete exits history, request access »

Changchun High and New Technology Industries Group Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
GeneScience Pharmaceuticals Co. Changchun, China 1996

Changchun High and New Technology Industries Group FAQs

  • When was Changchun High and New Technology Industries Group founded?

    Changchun High and New Technology Industries Group was founded in 1993.

  • Where is Changchun High and New Technology Industries Group headquartered?

    Changchun High and New Technology Industries Group is headquartered in Changchun, China.

  • What is the size of Changchun High and New Technology Industries Group?

    Changchun High and New Technology Industries Group has 10,080 total employees.

  • What industry is Changchun High and New Technology Industries Group in?

    Changchun High and New Technology Industries Group’s primary industry is Biotechnology.

  • Is Changchun High and New Technology Industries Group a private or public company?

    Changchun High and New Technology Industries Group is a Public company.

  • What is Changchun High and New Technology Industries Group’s stock symbol?

    The ticker symbol for Changchun High and New Technology Industries Group is 000661.

  • What is the current stock price of Changchun High and New Technology Industries Group?

    As of 13-Nov-2026 the stock price of Changchun High and New Technology Industries Group is $10.56.

  • What is the current market cap of Changchun High and New Technology Industries Group?

    The current market capitalization of Changchun High and New Technology Industries Group is $4.31B.

  • What is Changchun High and New Technology Industries Group’s current revenue?

    The trailing twelve month revenue for Changchun High and New Technology Industries Group is $1.53B.

  • What is Changchun High and New Technology Industries Group’s annual earnings per share (EPS)?

    Changchun High and New Technology Industries Group’s EPS for 12 months was -$0.15.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process